You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Resectable Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

Recruiting
  • Breast Cancer
  • Los Angeles, California
  • +2 more
Sep 27, 2022

Breast Cancer Trial in New York (Cryoablation, Ipilimumab, Nivolumab)

Active, not recruiting
  • Breast Cancer
  • Cryoablation
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 1, 2022

Breast Cancer Female, Early-stage Breast Cancer Trial in Jette (Trimix, Placebo)

Recruiting
  • Breast Cancer Female
  • Early-stage Breast Cancer
  • Jette, Brussel, Belgium
    UZ Brussel
May 18, 2022

Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Proleukin 1.3 MG Injection
  • (no location specified)
Apr 6, 2023

Breast Adenocarcinoma, Invasive Breast Carcinoma, Resectable Breast Carcinoma Trial in Jacksonville (Biospecimen Collection,

Recruiting
  • Breast Adenocarcinoma
  • +2 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 4, 2023

HER2 Positive Non Resectable or Metastatic Breast Cancer Trial (SHR-A1811:Pyrroltinib, SHR-A1811;Pertuzumab, SHR-A1811;SHR-1316)

Not yet recruiting
  • HER2 Positive Non Resectable or Metastatic Breast Cancer
  • (no location specified)
Apr 25, 2022

Breast Cancer Trial in Birmingham (Letrozole, Everolimus, TRC105)

Active, not recruiting
  • Breast Cancer
  • Birmingham, Alabama
    University of Alabama at Birmingham
Dec 13, 2022

Ultrasound Conspicuity, and Migration of Twinkling Markers in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +2 more
  • Magnetic Resonance Imaging
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

HER2-positive Metastatic Breast Cancer, Locally Advanced HER2 Positive Breast Carcinoma Trial in Spain (Tucatinib, Trastuzumab,

Not yet recruiting
  • HER2-positive Metastatic Breast Cancer
  • Locally Advanced HER2 Positive Breast Carcinoma
  • Cádiz, Andalucía, Spain
  • +17 more
Jan 16, 2023

Liver Metastases, Liver Metastasis Colon Cancer, Colorectal Cancer Trial in Tampa (DNX-2440)

Recruiting
  • Liver Metastases
  • +10 more
  • DNX-2440
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute, Inc.
Mar 28, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Trastuzumab, Capecitabine)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, China
  • +9 more
Mar 11, 2022

NSCLC With Mutation in Epidermal Growth Factor Receptor Trial (Osimertinib, Aspirin)

Not yet recruiting
  • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
  • (no location specified)
Aug 27, 2023

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Pancreatic Cancer Trial in Shatin (MSLN CART)

Not yet recruiting
  • Pancreatic Cancer
  • MSLN CART
  • Shatin, N.t., Hong Kong
    Endoscopy Centre, Prince of Wales Hospital
Sep 19, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Tucson (Tadalafil 20 MG)

Not yet recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Tadalafil 20 MG
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Feb 1, 2023

Lung Cancer Trial (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Lung Cancer
  • (no location specified)
Sep 20, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

NSCLC Trial (Durvalumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Jun 22, 2023

Breast Cancer Trial in Bridgeport, New Haven, Providence (Abraxane, Carboplatin, Avastin)

Completed
Has Results
  • Breast Cancer
  • Bridgeport, Connecticut
  • +4 more
Apr 6, 2021

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

Colon Cancer Trial in Lexington (TVB-2640, Placebo)

Recruiting
  • Colon Cancer
  • Lexington, Kentucky
    University of Kentucky
Jan 18, 2023

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

NSCLC Trial in Beijing

Recruiting
  • NSCLC
    • Beijing, China
      Yuyan Wang
    Oct 10, 2023

    Metastatic Breast Cancer, Liver Metastases Trial in Herlev (oxaliplatin, capecitabine, trastuzumab)

    Completed
    • Metastatic Breast Cancer
    • Liver Metastases
    • oxaliplatin, capecitabine, trastuzumab
    • Herlev, Denmark
      Herlev Hospital
    Oct 1, 2020